Biotech Values

[JJM760]

I think by the time you get your engraved in stone data as to the cause of the SAE's, Ponatinib (Iclusig) will be well on it's way to gaining momentum as a leading CML drug. By that time, the PPS sale you are seeing now (and it may go lower) will have been a distant memory and another lost opportunity to invest in this company at a substantial discount to what it will be trading at in a few years.

FWIW, I am definitely not the smartest or most qualified man in this room, but I get the feeling that sometimes it's more important to some here to be right than to make money investing in biotech companies.

All possible respect to you JQ. I read your posts/tweets religiously. However, you have never been a big fan of Ariad and that includes when it was trading at $5.